Related references
Note: Only part of the references are listed.Genetic Heterogeneity of Circulating Cells from Patients with Lymphangioleiomyomatosis with and without Lung Transplantation
Wendy K. Steagall et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Models of Breast Morphogenesis Based on Localization of Stem Cells in the Developing Mammary Lobule
Gabriella Honeth et al.
STEM CELL REPORTS (2015)
Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival
N. P. Tobin et al.
ANNALS OF ONCOLOGY (2015)
Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells
Chenggang Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Tubers from patients with tuberous sclerosis complex are characterized by changes in microtubule biology through ROCK2 signalling
Isidre Ferrer et al.
JOURNAL OF PATHOLOGY (2014)
Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq
Barbara Treutlein et al.
NATURE (2014)
In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor
Ling Gao et al.
VIRCHOWS ARCHIV (2014)
The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis
Sean P. Delaney et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2014)
Exonic Mutations of TSC2/TSC1 Are Common but Not Seen in All Sporadic Pulmonary Lymphangioleiomyomatosis
Kameswara Rao Badri et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Id-1 Is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target
Liliana Soroceanu et al.
CANCER RESEARCH (2013)
Small-Molecule Inhibitors of USP1 Target ID1 Degradation in Leukemic Cells
Helena Mistry et al.
MOLECULAR CANCER THERAPEUTICS (2013)
eIF4F suppression in breast cancer affects maintenance and progression
Z. Nasr et al.
ONCOGENE (2013)
Lymphangioleiomyomatosis Calling It What It Is: A Low-Grade, Destructive, Metastasizing Neoplasm
Francis X. McCormack et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State
Wenjun Guo et al.
CELL (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Andrew C. Hsieh et al.
NATURE (2012)
KEGG for integration and interpretation of large-scale molecular data sets
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2012)
CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling
P-K Lo et al.
ONCOGENE (2012)
Id1 Maintains Embryonic Stem Cell Self-Renewal by Up-Regulation of Nanog and Repression of Brachyury Expression
Elizabeth E. Romero-Lanman et al.
STEM CELLS AND DEVELOPMENT (2012)
Genome-Wide Joint Meta-Analysis of SNP and SNP-by-Smoking Interaction Identifies Novel Loci for Pulmonary Function
Dana B. Hancock et al.
PLOS GENETICS (2012)
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
Sean D. McAllister et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
An emerging role for TOR signaling in mammalian tissue and stem cell physiology
Ryan C. Russell et al.
DEVELOPMENT (2011)
Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer
Geetika Chakravarty et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
The roles of fascins in health and disease
Yosuke Hashimoto et al.
JOURNAL OF PATHOLOGY (2011)
Lymphangiomatosis: Clinical Overview
Francine Blei
LYMPHATIC RESEARCH AND BIOLOGY (2011)
mTOR: from growth signal integration to cancer, diabetes and ageing
Roberto Zoncu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
Francis X. McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Phenotypic Characterization of Disseminated Cells with TSC2 Loss of Heterozygosity in Patients with Lymphangioleiomyomatosis
Xiong Cai et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
TACC3-TSC2 maintains nuclear envelope structure and controls cell division
Laia Gomez-Baldo et al.
CELL CYCLE (2010)
Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma
Eisuke Kobayashi et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Lymphangioleiomyomatosis: A Disease Involving the Lymphatic System
Kuniaki Seyama et al.
LYMPHATIC RESEARCH AND BIOLOGY (2010)
mTOR Activation, Lymphangiogenesis, and Estrogen-Mediated Cell Survival: The Perfect Storm of Pro-Metastatic Factors in LAM Pathogenesis
Jane Yu et al.
LYMPHATIC RESEARCH AND BIOLOGY (2010)
The Natural History of Lymphangioleiomyomatosis: Markers of Severity, Rate of Progression and Prognosis
Angelo M. Taveira-DaSilva et al.
LYMPHATIC RESEARCH AND BIOLOGY (2010)
The Role of Chemokines in Migration of Metastatic-like Lymphangioleiomyomatosis Cells
Gustavo Pacheco-Rodriguez et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2010)
Apigenin inhibits proliferation of ovarian cancer A2780 cells through Id1
Zhao-dong Li et al.
FEBS LETTERS (2009)
TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex
D. A. Muzykewicz et al.
JOURNAL OF MEDICAL GENETICS (2009)
A six-gene signature predicting breast cancer lung metastasis
Thomas Landemaine et al.
CANCER RESEARCH (2008)
Subtypes of breast cancer show preferential site of relapse
Marcel Smid et al.
CANCER RESEARCH (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Lymphangioleiomyomatosis - A clinical update
Francis X. McCormack
CHEST (2008)
Lymphangioleiomyomatosis: A review
Donald W. Hohman et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2008)
mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization
Boyi Gan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance
Jiangbing Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Protein kinase A-regulated nucleocytoplasmic shuttling of Id1 during angiogenesis
Koichi Nishiyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The tuberous sclerosis complex
Peter B. Crino et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Elevated phosphorylation and activation of PDK-I/AKT pathway in human breast cancer
HJ Lin et al.
BRITISH JOURNAL OF CANCER (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
ID family of helix-loop-helix proteins in cancer
J Perk et al.
NATURE REVIEWS CANCER (2005)
Genes that mediate breast cancer metastasis to lung
AJ Minn et al.
NATURE (2005)
Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer:: The role of promoter methylation of TSC genes
WG Jiang et al.
EUROPEAN JOURNAL OF CANCER (2005)
Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis
DM Crooks et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3
QL Ying et al.
CELL (2003)
Recurrent lymphangiomyomatosis after transplantation - Genetic analyses reveal a metastatic mechanism
M Karbowniczek et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Recurrence of lymphangioleiomyomatosis after single lung transplantation: New insights into pathogenesis
I Bittmann et al.
HUMAN PATHOLOGY (2003)
Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ
W Boecker et al.
JOURNAL OF PATHOLOGY (2002)
Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis
T Sato et al.
JOURNAL OF HUMAN GENETICS (2002)
Id proteins - Tumor markers or oncogenes?
J Hasskarl et al.
CANCER BIOLOGY & THERAPY (2002)
Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis
T Carsillo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis
A Astrinidis et al.
JOURNAL OF MEDICAL GENETICS (2000)
Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy - An immunohistochemical study
K Matsui et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
